Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop (Q34386133)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop |
scientific article |
Statements
1 reference
Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop (English)
1 reference
De Gruttola VG
1 reference
Clax P
1 reference
DeMets DL
1 reference
Downing GJ
1 reference
Ellenberg SS
1 reference
Friedman L
1 reference
Gail MH
1 reference
Prentice R
1 reference
Wittes J
1 reference
Zeger SL
1 reference
1 October 2001
1 reference
1 reference
22
1 reference
5
1 reference
485-502
1 reference
Identifiers
1 reference
1 reference